Paradigm Biopharmaceuticals (ASX:PAR) Price-to-Tangible-Book : 3.18 (As of May. 14, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Paradigm Biopharmaceuticals Price-to-Tangible-Book?

As of today (2024-05-14), Paradigm Biopharmaceuticals's share price is A$0.28. Paradigm Biopharmaceuticals's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was A$0.09. Hence, Paradigm Biopharmaceuticals's Price to Tangible Book Ratio of today is 3.18.

The historical rank and industry rank for Paradigm Biopharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

ASX:PAR' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3 Med: 6.76 Max: 20.43
Current: 3.11

During the past 8 years, Paradigm Biopharmaceuticals's highest Price to Tangible Book Ratio was 20.43. The lowest was 3.00. And the median was 6.76.

ASX:PAR's Price-to-Tangible-Book is ranked worse than
53.77% of 1220 companies
in the Biotechnology industry
Industry Median: 2.71 vs ASX:PAR: 3.11

A closely related ratio is called PB Ratio. As of today, Paradigm Biopharmaceuticals's share price is A$0.28. Paradigm Biopharmaceuticals's Book Value per Sharefor the quarter that ended in Dec. 2023 was A$0.10. Hence, Paradigm Biopharmaceuticals's P/B Ratio of today is 2.92.

Paradigm Biopharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Paradigm Biopharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paradigm Biopharmaceuticals Price-to-Tangible-Book Chart

Paradigm Biopharmaceuticals Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Tangible-Book

Get a 7-Day Free Trial

3.37

6.73

6.42

5.72

5.50

Paradigm Biopharmaceuticals Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial												8.75	5.72	5.60	5.50	4.83

Competitive Comparison of Paradigm Biopharmaceuticals's Price-to-Tangible-Book

For the Biotechnology subindustry, Paradigm Biopharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Paradigm Biopharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Paradigm Biopharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Paradigm Biopharmaceuticals's Price-to-Tangible-Book falls into.

Paradigm Biopharmaceuticals Price-to-Tangible-Book Calculation

Paradigm Biopharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.28	/	0.088
	=	3.18

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Paradigm Biopharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Paradigm Biopharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Paradigm Biopharmaceuticals (ASX:PAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Paradigm Biopharmaceuticals Ltd (ASX:PAR) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

PBIGF:USA

Address

500 Collins Street, Level 15, Melbourne, VIC, AUS, 3000

Website

https://www.paradigmbiopharma.com

Paradigm Biopharmaceuticals Ltd is a biopharmaceutical company that engages in the research and development of therapeutic products for human use in Australia. The firm is engaged in drug repurposing, pentosan polysulphate sodium (PPS) for the lead clinical indication of bone marrow edema, Alphavirus - Ross River virus (RRV) and Chikungunya virus (CHIKV), Mucopolysaccharidosis, and allergic respiratory conditions, including allergic rhinitis (AR) and chronic obstructive pulmonary disease (COPD).